A
ADH
Antidiuretic hormone (ADH), also called vasopressin, is a peptide hormone synthesized primarily in the supraoptic and paraventricular nuclei of the hypothalamus and released from the posterior pituitary. It regulates body water balance by increasing water reabsorption in the renal collecting ducts and, at higher concentrations, can produce vasoconstriction.
Region-
SystemEndocrine System
Antidiuretic hormone (ADH), also called arginine vasopressin (AVP) or simply vasopressin, is a peptide hormone that plays a central role in the regulation of body water balance, plasma osmolality, and cardiovascular homeostasis. Unlike the major hormones of the anterior pituitary, ADH is synthesized in the hypothalamus rather than in the pituitary gland itself.
ADH is produced primarily by magnocellular neurosecretory neurons in the supraoptic nucleus and paraventricular nucleus of the hypothalamus. After synthesis, the hormone is transported along axons through the hypothalamo-hypophyseal tract to the posterior pituitary, where it is stored in nerve terminals and released into the systemic circulation.
The major physiological action of ADH occurs in the kidney. By acting on V2 receptors in collecting duct principal cells, ADH promotes insertion of aquaporin-2 water channels into the apical membrane. This increases water reabsorption, concentrates the urine, and helps maintain plasma osmolality and extracellular fluid volume.
Hormone Classification
ADH is a peptide hormone composed of nine amino acids and is therefore classified as a nonapeptide.
Its structure is closely related to that of oxytocin, the other major hormone released from the posterior pituitary.
ADH and Vasopressin
The terms ADH and vasopressin refer to the same hormone. The name antidiuretic hormone emphasizes its ability to conserve water by reducing urinary water loss.
The name vasopressin reflects its ability, particularly at higher concentrations, to constrict blood vessels and increase vascular resistance.
Site of ADH Synthesis
ADH is synthesized in specialized magnocellular neurosecretory neurons located within the hypothalamus.
The two most important nuclei involved are the supraoptic nucleus and paraventricular nucleus.
Supraoptic Nucleus
The supraoptic nucleus (SON) lies superior to the optic chiasm and contains large neurosecretory neurons that prominently synthesize vasopressin.
Axons from these neurons descend through the hypothalamo-hypophyseal tract and terminate within the posterior pituitary.
Paraventricular Nucleus
The paraventricular nucleus (PVN) lies adjacent to the third ventricle and contains multiple populations of neurosecretory neurons.
Magnocellular neurons within the PVN can synthesize ADH as well as oxytocin-producing neuronal populations. Their axons project directly to the posterior pituitary.
ADH Synthesis and Processing
ADH is initially synthesized as part of a larger precursor protein within the cell bodies of hypothalamic neurons.
The precursor contains vasopressin, neurophysin II, and a glycopeptide known as copeptin. Processing occurs during transport through the neurosecretory pathway.
Neurophysin II
Neurophysin II is a carrier protein associated with vasopressin during its intracellular transport from the hypothalamus to the posterior pituitary.
ADH and neurophysin II originate from the same precursor and travel together within neurosecretory vesicles.
Copeptin
Copeptin is the C-terminal portion of the vasopressin precursor and is released together with vasopressin.
Because copeptin is more stable in blood than vasopressin, it can serve as a useful surrogate marker of endogenous vasopressin secretion in selected clinical evaluations.
Hypothalamo-Hypophyseal Tract
The hypothalamo-hypophyseal tract consists of axons extending from magnocellular neurons of the supraoptic and paraventricular nuclei to the posterior pituitary.
This neural connection distinguishes posterior pituitary hormone release from the portal vascular mechanism controlling the anterior pituitary.
Axonal Transport
After synthesis in hypothalamic neuronal cell bodies, ADH-containing secretory vesicles are transported along axons toward the posterior pituitary.
During this journey, the precursor is processed and mature hormone becomes available for release from neurosecretory terminals.
Posterior Pituitary
The posterior pituitary, or neurohypophysis, does not synthesize ADH. Instead, it contains axon terminals of hypothalamic neurosecretory neurons and provides the site from which ADH enters the systemic circulation.
The major hormone-releasing portion of the posterior pituitary is the pars nervosa.
Pars Nervosa
The pars nervosa contains unmyelinated axons and neurosecretory terminals originating from hypothalamic magnocellular neurons.
These terminals lie close to fenestrated capillaries, allowing released ADH to enter the bloodstream rapidly.
Herring Bodies
Herring bodies are dilated portions of neurosecretory axons containing accumulations of hormone-containing secretory granules.
They can be observed within the posterior pituitary and along the hypothalamo-hypophyseal tract and are associated with storage of neurohypophyseal hormones.
Pituicytes
Pituicytes are specialized glial cells of the posterior pituitary. They support the axons and neurosecretory terminals of hypothalamic neurons.
Pituicytes do not themselves synthesize ADH or oxytocin.
ADH Release Pathway
| Step | Event |
|---|---|
| 1 | ADH precursor is synthesized in hypothalamic magnocellular neurons |
| 2 | Hormone-containing vesicles enter hypothalamic axons |
| 3 | Vesicles travel through the hypothalamo-hypophyseal tract |
| 4 | ADH is stored in neurosecretory terminals of the posterior pituitary |
| 5 | Action potentials reach the nerve terminals |
| 6 | Calcium-dependent exocytosis releases ADH |
| 7 | ADH enters posterior pituitary capillaries |
| 8 | Systemic circulation carries ADH to target organs |
Regulation of ADH Secretion
ADH secretion is regulated primarily by changes in plasma osmolality and by changes in effective circulating volume and arterial pressure.
These regulatory systems allow ADH to coordinate water conservation with cardiovascular homeostasis.
Plasma Osmolality
Plasma osmolality reflects the concentration of osmotically active substances within plasma. Sodium and its associated anions make the largest contribution to effective extracellular fluid osmolality.
Even relatively small increases in plasma osmolality can stimulate ADH secretion.
Hypothalamic Osmoreceptors
Specialized osmosensitive neural mechanisms detect changes in extracellular fluid osmolality and regulate magnocellular vasopressin neurons.
When plasma osmolality rises, ADH secretion increases. When plasma osmolality falls, ADH secretion is normally suppressed.
Osmotic Regulation
| Change | ADH Response | Renal Effect |
|---|---|---|
| Increased plasma osmolality | ADH increases | Water reabsorption increases |
| Decreased plasma osmolality | ADH decreases | Water excretion increases |
Thirst and ADH
Osmotic regulation of ADH is closely integrated with the neural mechanisms controlling thirst.
As extracellular fluid becomes hyperosmotic, increased ADH conserves existing body water while thirst promotes additional water intake.
Blood Volume Regulation
A substantial reduction in circulating blood volume strongly stimulates ADH secretion, even when plasma osmolality is not elevated.
This response prioritizes maintenance of effective circulating volume and arterial pressure during significant hypovolemia.
Baroreceptor Regulation
Pressure-sensitive receptors in the cardiovascular system provide neural information relevant to ADH secretion.
Reduced stretch associated with decreased blood pressure or circulating volume can increase vasopressin release through central neural pathways.
Nonosmotic ADH Release
Several stimuli can promote ADH secretion independently of increased plasma osmolality. Important examples include substantial volume depletion, hypotension, nausea, pain, and physiological stress.
Nausea is particularly capable of producing strong vasopressin secretion.
Factors Affecting ADH Secretion
| Factor | General Effect on ADH |
|---|---|
| Increased plasma osmolality | Increases |
| Reduced circulating volume | Increases |
| Reduced arterial pressure | Increases |
| Nausea | Strongly increases |
| Pain and stress | Can increase |
| Low plasma osmolality | Suppresses |
| Alcohol | Can suppress vasopressin release |
Kidney as the Major Target
The kidney is the principal target responsible for the antidiuretic action of ADH.
ADH acts predominantly on principal cells in the late distal nephron and collecting duct system, increasing their permeability to water.
Collecting Duct
The collecting duct is the final major site at which hormonal regulation can substantially alter urinary water excretion.
Without significant ADH activity, the collecting ducts have relatively low water permeability. With ADH stimulation, their water permeability increases markedly.
Principal Cells
Principal cells are epithelial cells within the collecting duct that participate in sodium, potassium, and water handling.
ADH binds V2 receptors on the basolateral membrane of these cells and stimulates insertion of aquaporin-2 channels into the apical membrane.
V2 Receptors
V2 receptors are G protein-coupled vasopressin receptors expressed prominently on renal collecting duct principal cells.
Activation of V2 receptors stimulates Gs proteins, adenylyl cyclase, cyclic AMP production, and protein kinase A signaling.
Aquaporin-2
Aquaporin-2 (AQP2) is an ADH-regulated water channel located in collecting duct principal cells.
In response to V2 receptor activation, intracellular vesicles containing AQP2 fuse with the apical plasma membrane, greatly increasing water permeability.
Renal ADH Signaling
| Step | Event |
|---|---|
| 1 | ADH reaches the kidney through systemic blood |
| 2 | ADH binds V2 receptors on collecting duct principal cells |
| 3 | Gs activates adenylyl cyclase |
| 4 | Intracellular cAMP increases |
| 5 | Protein kinase A signaling increases |
| 6 | AQP2-containing vesicles move toward the apical membrane |
| 7 | AQP2 channels are inserted into the membrane |
| 8 | Collecting duct water permeability increases |
Water Reabsorption
Water enters principal cells from the tubular lumen through apical AQP2 channels when an osmotic gradient favors water movement.
Water then exits across the basolateral membrane through other aquaporin channels and returns to the circulation through the renal interstitium and capillaries.
Renal Medullary Osmotic Gradient
ADH-mediated water conservation depends on the hyperosmotic renal medullary interstitium. The medullary concentration gradient provides the driving force for water to leave the collecting duct.
Countercurrent mechanisms, urea handling, and renal medullary architecture contribute to maintenance of this gradient.
ADH and Urea
ADH also increases urea permeability in portions of the inner medullary collecting duct.
Urea recycling contributes to the high osmolality of the inner renal medulla and therefore supports the kidney's ability to produce concentrated urine.
Concentrated Urine
When ADH concentrations are high and the medullary osmotic gradient is intact, substantial amounts of water can be reabsorbed from the collecting ducts.
Urine volume decreases while urine osmolality increases.
Dilute Urine
When ADH secretion is suppressed, relatively few AQP2 channels remain inserted in the apical collecting duct membrane.
The collecting ducts therefore reabsorb less water, allowing larger volumes of dilute urine to be excreted.
Effects of ADH on Urine
| Feature | High ADH | Low ADH |
|---|---|---|
| Collecting duct water permeability | Increased | Reduced |
| AQP2 membrane insertion | Increased | Reduced |
| Water reabsorption | Increased | Reduced |
| Urine volume | Reduced | Increased |
| Urine concentration | Increased | Decreased |
V1 Receptors
Vasopressin also acts through V1 receptors. V1a receptors are expressed on vascular smooth muscle and several other tissues.
Activation of vascular V1a receptors promotes smooth muscle contraction and vasoconstriction.
V1 Receptor Signaling
V1 receptors predominantly signal through the Gq pathway. Activation stimulates phospholipase C, generating intracellular signals that increase cytosolic calcium.
In vascular smooth muscle, increased intracellular calcium promotes contraction.
Vasoconstriction
At sufficiently high concentrations, vasopressin produces vasoconstriction and increases systemic vascular resistance.
This effect becomes particularly relevant during severe hypotension or marked loss of circulating volume, when vasopressin secretion can rise substantially.
V1b Receptors
V1b receptors, also called V3 receptors in some classifications, are expressed on anterior pituitary corticotrophs.
Vasopressin acting through these receptors can enhance ACTH secretion, particularly in combination with CRH during activation of the hypothalamic-pituitary-adrenal axis.
Major Vasopressin Receptors
| Receptor | Important Location | Major Effect |
|---|---|---|
| V1a | Vascular smooth muscle | Vasoconstriction |
| V1b | Anterior pituitary corticotrophs | Facilitates ACTH secretion |
| V2 | Renal collecting duct principal cells | Increases water reabsorption |
ADH and Blood Pressure
ADH can support blood pressure through two complementary mechanisms. Renal V2 receptor activation conserves water and helps maintain circulating volume, while vascular V1a receptor activation can increase vascular resistance.
The vascular effect is most important when circulating vasopressin concentrations become substantially elevated.
ADH and the Renin-Angiotensin System
ADH interacts functionally with other systems that defend extracellular fluid volume and arterial pressure, including the renin-angiotensin-aldosterone system.
Angiotensin II can promote thirst, sodium retention pathways, and vasopressin release, coordinating water and sodium conservation during volume depletion.
ADH and Aldosterone
ADH and aldosterone both influence renal handling of body fluids, but their primary actions differ.
ADH primarily regulates water permeability and water balance, whereas aldosterone primarily promotes sodium reabsorption and potassium secretion in the distal nephron.
ADH Versus Aldosterone
| Feature | ADH | Aldosterone |
|---|---|---|
| Primary source | Hypothalamus, released from posterior pituitary | Adrenal cortex |
| Hormone class | Peptide | Steroid |
| Major renal target | Collecting duct principal cells | Distal nephron principal cells |
| Major regulated substance | Water | Sodium and potassium |
| Important receptor | V2 receptor | Mineralocorticoid receptor |
ADH and Oxytocin
ADH and oxytocin are structurally related nonapeptide hormones synthesized by hypothalamic magnocellular neurons and released from the posterior pituitary.
Despite their anatomical similarities, they have distinct principal physiological functions.
ADH Versus Oxytocin
| Feature | ADH | Oxytocin |
|---|---|---|
| Synthesis | Hypothalamic magnocellular neurons | Hypothalamic magnocellular neurons |
| Release | Posterior pituitary | Posterior pituitary |
| Major target | Kidney | Uterus and mammary gland |
| Major function | Water conservation | Uterine contraction and milk ejection |
| Peptide length | 9 amino acids | 9 amino acids |
Posterior Versus Anterior Pituitary Hormones
ADH demonstrates a fundamental difference between the posterior and anterior pituitary. The posterior pituitary stores and releases hormones synthesized in hypothalamic neurons.
In contrast, anterior pituitary endocrine cells synthesize hormones such as ACTH, TSH, growth hormone, prolactin, LH, and FSH in response to hypothalamic regulatory signals delivered largely through the portal circulation.
Posterior Pituitary Hormones
| Hormone | Site of Synthesis | Site of Release | Major Function |
|---|---|---|---|
| ADH | Hypothalamus | Posterior pituitary | Water conservation and vasoconstriction |
| Oxytocin | Hypothalamus | Posterior pituitary | Uterine contraction and milk ejection |
Central Diabetes Insipidus
Central diabetes insipidus results from inadequate synthesis or release of ADH. Causes can involve the hypothalamus, pituitary stalk, or posterior pituitary neurosecretory system.
Insufficient ADH prevents appropriate concentration of urine, leading to excretion of large volumes of dilute urine.
Features of Central Diabetes Insipidus
Loss of effective ADH activity can produce polyuria and compensatory polydipsia. If water intake cannot keep pace with urinary water loss, plasma sodium and osmolality can rise.
The severity depends on the degree of ADH deficiency and the individual's access to water and intact thirst mechanism.
Nephrogenic Diabetes Insipidus
Nephrogenic diabetes insipidus occurs when ADH is present but the kidneys cannot respond appropriately to it.
Defects involving V2 receptor signaling, aquaporin pathways, medications, electrolyte abnormalities, or acquired renal disorders can impair the renal response to vasopressin.
Central Versus Nephrogenic Diabetes Insipidus
| Feature | Central DI | Nephrogenic DI |
|---|---|---|
| Primary problem | Insufficient ADH production or release | Renal resistance to ADH |
| ADH pathway | Deficient central secretion | Hormone may be appropriately elevated |
| Urine | Dilute | Dilute |
| Response to desmopressin | Usually increases urine concentration | Reduced or absent depending on cause |
Desmopressin
Desmopressin (DDAVP) is a synthetic vasopressin analogue with strong antidiuretic activity at V2 receptors and relatively little vasoconstrictor activity compared with vasopressin.
It is commonly used to replace deficient antidiuretic activity in central diabetes insipidus and has additional clinical applications related to V2 receptor effects.
SIADH
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) describes inappropriate antidiuretic activity relative to plasma osmolality and volume status.
Excess renal water retention lowers plasma osmolality and can produce dilutional hyponatremia while the urine remains inappropriately concentrated.
Hyponatremia in SIADH
The reduced serum sodium concentration in SIADH primarily reflects retention of water rather than a primary increase in renal sodium loss.
The resulting hypo-osmolality can cause movement of water into cells, including neurons, making severe or rapidly developing hyponatremia clinically important.
Causes of Inappropriate ADH Activity
Inappropriate vasopressin activity can occur in association with disorders of the central nervous system, pulmonary disease, medications, malignancies producing ectopic vasopressin, postoperative states, pain, and nausea.
Interpretation requires assessment of serum osmolality, urine osmolality, urine sodium, volume status, and other potential causes of hyponatremia.
ADH and Hyponatremia
Persistent ADH activity limits the kidney's ability to excrete free water. If water intake continues, retained water can dilute extracellular sodium concentration.
ADH is therefore an important physiological determinant of many forms of hypotonic hyponatremia.
ADH and Hypernatremia
Hypernatremia generally reflects a relative deficit of body water compared with sodium. Increased plasma osmolality normally produces strong ADH secretion and thirst.
Hypernatremia can therefore develop when water losses exceed replacement, when thirst or access to water is impaired, or when the ADH pathway cannot adequately conserve water.
Water Deprivation
Water deprivation raises plasma osmolality and normally stimulates endogenous ADH secretion. The kidneys respond by increasing collecting duct water permeability and concentrating the urine.
Failure to concentrate urine appropriately can indicate a defect in ADH secretion, renal responsiveness, or the renal concentrating mechanism.
Water Deprivation Testing
A controlled water deprivation test has historically been used in the evaluation of polyuria-polydipsia syndromes.
Changes in urine concentration during water deprivation and after administration of desmopressin can provide information about endogenous ADH function and renal responsiveness, although modern diagnostic approaches may incorporate copeptin-based testing.
ADH and Hemorrhage
Significant blood loss reduces effective circulating volume and arterial pressure, providing a strong nonosmotic stimulus for ADH release.
Elevated vasopressin helps conserve renal water and, at sufficiently high concentrations, can support vascular tone through V1a-mediated vasoconstriction.
ADH and Nausea
Nausea is a powerful nonosmotic stimulus for vasopressin secretion.
Marked ADH release during nausea can temporarily reduce free-water excretion even when plasma osmolality would otherwise favor suppression of the hormone.
ADH and Alcohol
Alcohol can suppress vasopressin secretion under some circumstances, reducing collecting duct water reabsorption and contributing to increased urine production.
The overall fluid effects of alcohol depend on dose, hydration status, intake of other fluids, and additional physiological factors.
ADH and the HPA Axis
Vasopressin also participates in regulation of the hypothalamic-pituitary-adrenal axis. Parvocellular hypothalamic vasopressin can act with CRH to stimulate anterior pituitary corticotrophs.
This action occurs through V1b receptors and can enhance ACTH secretion during stress.
ADH Receptor Summary
| Receptor | Signaling | Major Site | Effect |
|---|---|---|---|
| V1a | Gq, phospholipase C | Vascular smooth muscle | Vasoconstriction |
| V1b | Gq, phospholipase C | Anterior pituitary | Enhances ACTH secretion |
| V2 | Gs, cAMP | Renal collecting duct | Increases water reabsorption |
ADH Versus ACTH
| Feature | ADH | ACTH |
|---|---|---|
| Site of synthesis | Hypothalamus | Anterior pituitary |
| Pituitary relationship | Stored and released from posterior pituitary | Synthesized and released by anterior pituitary |
| Major target | Kidney | Adrenal cortex |
| Major function | Water conservation | Stimulates cortisol production |
ADH Versus Renin-Angiotensin-Aldosterone System
ADH and the renin-angiotensin-aldosterone system cooperate in defending circulating volume but regulate different aspects of renal fluid handling.
ADH primarily controls free-water conservation, whereas angiotensin II and aldosterone strongly influence sodium balance, vascular tone, and extracellular fluid volume.
Key Features of ADH
| Feature | Key Point |
|---|---|
| Full name | Antidiuretic hormone |
| Alternative names | Arginine vasopressin, vasopressin |
| Hormone class | Peptide hormone |
| Length | 9 amino acids |
| Primary synthesis sites | Supraoptic and paraventricular nuclei of hypothalamus |
| Neuronal type | Magnocellular neurosecretory neurons |
| Transport pathway | Hypothalamo-hypophyseal tract |
| Storage and release site | Posterior pituitary |
| Major target | Renal collecting duct |
| Major renal receptor | V2 |
| Major regulated water channel | Aquaporin-2 |
| Major physiological effect | Increased water reabsorption |
| Vascular receptor | V1a |
| Major stimuli | Increased plasma osmolality and decreased effective circulating volume |
Anatomical and Physiological Importance
ADH demonstrates the direct neural relationship between the hypothalamus and posterior pituitary. Magnocellular neurons in the supraoptic and paraventricular nuclei synthesize vasopressin within their cell bodies. The hormone is packaged into neurosecretory vesicles and transported down long axons forming the hypothalamo-hypophyseal tract.
These axons terminate within the pars nervosa of the posterior pituitary. When the magnocellular neurons generate action potentials, depolarization of their terminals triggers calcium-dependent exocytosis, releasing ADH into nearby capillaries and therefore directly into the systemic circulation. The posterior pituitary consequently functions primarily as a neural storage and release organ rather than as the site of ADH synthesis.
Circulating ADH acts principally on V2 receptors of renal collecting duct principal cells. Through Gs, cAMP, and protein kinase A signaling, it promotes insertion of aquaporin-2 channels into the apical membrane. Water can then move from tubular fluid into the hyperosmotic renal medulla and ultimately return to the circulation. This mechanism allows the kidneys to vary urine concentration dramatically according to the body's water requirements.
ADH secretion is closely linked to hypothalamic osmoregulation. Rising plasma osmolality stimulates vasopressin secretion and thirst, coordinating water conservation with water intake. Significant reductions in circulating volume or blood pressure provide powerful nonosmotic stimuli that can override ordinary osmotic regulation. During severe hypovolemia, vasopressin can simultaneously conserve renal water and support vascular resistance through V1a receptors.
Disorders of this system illustrate the importance of each anatomical component. Damage to hypothalamic neurons, the pituitary stalk, or the neurohypophyseal pathway can cause central diabetes insipidus. Renal resistance to vasopressin causes nephrogenic diabetes insipidus. Conversely, persistent inappropriate antidiuretic activity can impair free-water excretion and produce the hypo-osmolality and hyponatremia characteristic of SIADH.
Through its hypothalamic synthesis, axonal transport, posterior pituitary release, renal V2 receptor signaling, vascular V1 receptor activity, and precise osmotic and volume-dependent regulation, ADH provides a major neuroendocrine mechanism for maintaining water balance and circulatory homeostasis.
Published on October 1, 2026
Last updated on October 1, 2026
Last updated on October 1, 2026